disclosed that they own a 10.2% stake in Abeona Therapeutics Inc (NASDAQ:ABEO) in a Schedule 13G/A disclosure that was filed with the SEC on Monday, March 12th. The investor owns 4,779,191 shares of the stock valued at $76,467,056. The filing is available through Edgar at this link.
Abeona Therapeutics Inc (NASDAQ:ABEO) traded up $0.70 during trading on Monday, hitting $16.00. 739,691 shares of the stock traded hands, compared to its average volume of 1,144,020. Abeona Therapeutics Inc has a twelve month low of $4.55 and a twelve month high of $22.75. The stock has a market cap of $715.66, a PE ratio of -24.09 and a beta of 1.30.
Several analysts recently issued reports on ABEO shares. Zacks Investment Research raised shares of Abeona Therapeutics from a “sell” rating to a “buy” rating and set a $18.00 price objective for the company in a research note on Wednesday, November 22nd. Maxim Group set a $35.00 price objective on shares of Abeona Therapeutics and gave the company a “buy” rating in a research note on Monday, November 20th. HC Wainwright reaffirmed a “buy” rating and set a $30.00 price objective on shares of Abeona Therapeutics in a research note on Thursday, February 1st. Royal Bank of Canada reaffirmed a “buy” rating and set a $26.00 price objective on shares of Abeona Therapeutics in a research note on Wednesday, January 24th. Finally, ValuEngine cut shares of Abeona Therapeutics from a “hold” rating to a “sell” rating in a research note on Friday, December 1st. Three research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus target price of $27.11.
TRADEMARK VIOLATION NOTICE: “Abeona Therapeutics Inc (ABEO) Stake Held by Fmr LLC” was originally posted by Markets Daily and is owned by of Markets Daily. If you are viewing this article on another publication, it was illegally stolen and republished in violation of United States and international copyright and trademark legislation. The correct version of this article can be read at https://www.themarketsdaily.com/2018/03/12/abeona-therapeutics-inc-abeo-stake-held-by-fmr-llc.html.
About Abeona Therapeutics
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel gene therapies for life-threatening rare genetic diseases. The Company’s lead programs include ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA) and EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB).
Want to see what other hedge funds are holding ABEO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Abeona Therapeutics Inc (NASDAQ:ABEO).
Receive News & Ratings for Abeona Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abeona Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.